Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India flag India · Delayed Price · Currency is INR
208.90
-8.44 (-3.88%)
May 11, 2026, 3:29 PM IST

Jagsonpal Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
14,10512,32314,4227,3137,5928,214
Market Cap Growth
-6.59%-14.55%97.22%-3.68%-7.58%293.91%
Enterprise Value
13,12610,81913,7416,2907,1757,748
Last Close Price
210.09184.03215.01108.21112.14121.33
PE Ratio
33.2928.6026.0532.5528.4143.57
PS Ratio
4.914.295.373.503.213.78
PB Ratio
5.114.466.013.904.786.19
P/TBV Ratio
7.126.229.353.904.786.19
P/FCF Ratio
30.2326.4126.2420.9416.39140.06
P/OCF Ratio
30.1326.3326.0820.8016.27118.81
EV/Sales Ratio
4.573.775.113.013.033.56
EV/EBITDA Ratio
22.6018.6327.6928.4420.6730.37
EV/EBIT Ratio
26.9922.2532.0029.1121.1832.30
EV/FCF Ratio
28.1323.1925.0118.0115.49132.10
Debt / Equity Ratio
0.030.030.040.050.04-
Debt / EBITDA Ratio
0.140.140.180.380.17-
Debt / FCF Ratio
0.180.180.170.260.13-
Net Debt / Equity Ratio
-0.35-0.35-0.50-0.74-0.68-0.35
Net Debt / EBITDA Ratio
-1.69-1.69-2.41-6.29-3.13-1.84
Net Debt / FCF Ratio
-2.10-2.10-2.17-3.98-2.34-8.02
Asset Turnover
0.970.971.091.011.321.33
Inventory Turnover
7.007.006.424.523.683.02
Quick Ratio
4.364.365.488.314.922.32
Current Ratio
5.065.066.2210.295.974.04
Return on Equity (ROE)
16.70%16.70%25.91%12.97%18.32%14.81%
Return on Assets (ROA)
10.22%10.22%10.84%6.55%11.79%9.13%
Return on Invested Capital (ROIC)
25.96%24.39%40.30%32.94%36.65%22.30%
Return on Capital Employed (ROCE)
16.90%16.90%17.00%10.90%20.20%17.50%
Earnings Yield
3.05%3.50%3.84%3.07%3.52%2.30%
FCF Yield
3.31%3.79%3.81%4.78%6.10%0.71%
Dividend Yield
1.84%2.17%1.16%1.85%1.78%1.32%
Payout Ratio
38.67%38.67%23.90%58.31%-55.58%
Buyback Yield / Dilution
-1.40%-1.40%-1.56%-1.23%--
Total Shareholder Return
0.44%0.77%-0.39%0.62%1.78%1.32%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.